Literature DB >> 1093650

Treatment of salmonella carriers with trimethoprim-sulfamethoxazole.

K J Clementi.   

Abstract

One hundred and two patients with salmonellosis were observed, as either acute cases or asymptomatic carriers, over a span of 6 years. Twenty-eight patients were treated with antibiotics only or received no treatment; those in the treated group became negative for the infecting organisms after a mean time of 160 days, as compared with a mean of 52.4 days for those who were not treated. Seventy-four other patients were treated with frimthoprim-sulfamethoxazole (TMP-SMX) as the sole medication or after prior antibiotic therapy. Sixty of these patients (81.1%) were free from Salmonella in the mean time of 19.2 days, whereas 14 failed to respond and the condition cleared spontaneously in a mean time of 134.9 days. The poor response to treatment with TMP-SMX by children 2 years of age and younger is noted. The beneficial effects of treatment with TMP-SMX, as compared with antibiotics or no treatment at all, are examined in the light of the need to protect the public from this potentially dangerous infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1093650      PMCID: PMC1956442     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  8 in total

1.  A study of infections due to pathogenic serogroups of Escherichia coli.

Authors:  N A HINTON; R R MACGREGOR
Journal:  Can Med Assoc J       Date:  1958-09-01       Impact factor: 8.262

2.  Appearance of specific colostrum antibodies after clinical infection with Salmonella typhimurium.

Authors:  R A Allardyce; D J Shearman; D B McClelland; K Marwick; A J Simpson; R B Laidlaw
Journal:  Br Med J       Date:  1974-08-03

Review 3.  Host resistance factors in human milk.

Authors:  A S Goldman; C W Smith
Journal:  J Pediatr       Date:  1973-06       Impact factor: 4.406

4.  Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae.

Authors:  B Aserkoff; J V Bennett
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

5.  Effect of trimethoprim-sulphamethoxazole on typhoid and salmonella carriers.

Authors:  J Brodie; I A Macqueen; D Livingstone
Journal:  Br Med J       Date:  1970-08-08

6.  Evaluation of trimethoprim-sulphamethoxazole compound in treatment of salmonella infections.

Authors:  A M Geddes; R Fothergill; J A Goodall; P R Dorken
Journal:  Br Med J       Date:  1971-08

7.  Treatment of Salmonella enteritis and its effect on the carrier state.

Authors:  E R Smith; B W Badley
Journal:  Can Med Assoc J       Date:  1971-06-05       Impact factor: 8.262

8.  Evaluation of therapeutic efficacy of trimethoprim-sulphamethoxazole and chloramphenicol in enteric fever.

Authors:  S A Kamat
Journal:  Br Med J       Date:  1970-08-08
  8 in total
  1 in total

Review 1.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.